Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.160
-0.020 (-1.69%)
At close: Sep 15, 2026, 4:00 PM EDT
1.141
-0.019 (-1.60%)
After-hours: Sep 15, 2026, 4:22 PM EDT
Inovio Pharmaceuticals Market Cap
Inovio Pharmaceuticals has a market cap or net worth of $119.94 million as of September 15, 2026. Its market cap has decreased by -5.18% in one year.
Market Cap
119.94M
Enterprise Value
91.27M
1-Year Change
-5.18%
Ranking
Category
Stock Price
$1.16
ChartMarket Cap Chart
Since March 31, 1999, Inovio Pharmaceuticals's market cap has increased from $71.80M to $119.94M, an increase of 67.05%. That is a compound annual growth rate of 1.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 119.94M | 28.69% |
| Dec 31, 2025 | 93.20M | 94.98% |
| Dec 31, 2024 | 47.80M | -65.66% |
| Dec 29, 2023 | 139.20M | -64.23% |
| Dec 30, 2022 | 389.20M | -62.93% |
| Dec 31, 2021 | 1.05B | -29.98% |
| Dec 31, 2020 | 1.50B | 354.33% |
| Dec 31, 2019 | 330.00M | -13.48% |
| Dec 31, 2018 | 381.40M | 2.28% |
| Dec 29, 2017 | 372.90M | -27.45% |
| Dec 30, 2016 | 514.00M | 5.96% |
| Dec 31, 2015 | 485.10M | -12.78% |
| Dec 31, 2014 | 556.20M | -7.96% |
| Dec 31, 2013 | 604.30M | 768.25% |
| Dec 31, 2012 | 69.60M | 27.71% |
| Dec 30, 2011 | 54.50M | -54.51% |
| Dec 31, 2010 | 119.80M | 2.92% |
| Dec 31, 2009 | 116.40M | 408.30% |
| Dec 31, 2008 | 22.90M | -43.18% |
| Dec 31, 2007 | 40.30M | -65.53% |
| Dec 29, 2006 | 116.90M | 163.88% |
| Dec 30, 2005 | 44.30M | -38.64% |
| Dec 31, 2004 | 72.20M | -1.77% |
| Dec 31, 2003 | 73.50M | 440.44% |
| Dec 31, 2002 | 13.60M | -37.04% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 130.64M |
| Biomea Fusion | 129.02M |
| Cellectis | 126.27M |
| enGene Therapeutics | 125.32M |
| OnKure Therapeutics | 121.49M |
| Aardvark Therapeutics | 121.46M |
| ProMIS Neurosciences | 118.91M |
| Black Diamond Therapeutics | 116.63M |